Recent developments in blood cell labeling researchSRIVASTAVA, S. C; STRAUB, R. F; MEINKEN, G. E et al.Acta radiologica. Supplementum. 1990, Num 374, pp 103-108, issn 0365-5954Article

Pancreas accumulation of radioiodinated HIPDM in mice and ratsYAMAMOTO, K; SOM, P; SRIVASTAVA, S. C et al.Journal of nuclear medicine. 1985, Vol 26, Num 7, pp 765-769, issn 0097-9058Article

Uptake of ruthenium-labeled transferrin in healing woundsHELSON, L; ROSENSPIRE, K; KAPELLARIS, A et al.International journal of nuclear medicine & biology. 1983, Vol 10, Num 4, pp 237-239, issn 0047-0740Article

Tin-117m(4+)-DTPA for palliation of pain from osseous metastases : a pilot studyATKINS, H. L; MAUSNER, L. F; SRIVASTAVA, S. C et al.The Journal of nuclear medicine (1978). 1995, Vol 36, Num 5, pp 725-729, issn 0161-5505Article

Introduction of five potentially metabolizable linking groups between ¹¹¹In-cyclohexyl EDTA derivatives and F(ab')₂ fragments of anti-carcinoembryonic antigen antibody. II: Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude miceFAIVRE-CHAUVET, A; GESTIN, J. F; MEASE, R. C et al.Nuclear medicine and biology. 1993, Vol 20, Num 6, pp 763-771, issn 0969-8051Article

Development of a new radiolabel (²⁰³Pb) and new chelating agents for labeling monoclonal antibodies for imagingSRIVASTAVA, S. C; MEASE, R. C; MEINKEN, G. E et al.Acta radiologica. Supplementum. 1990, Num 374, pp 135-140, issn 0365-5954Article

The development and in-vivo behavior of tin containing radiopharmaceuticals. II: Autoradiographic and scintigraphic studies in normal animals and in animal models of bone diseaseOSTER, Z. H; SOM, P; SRIVASTAVA, S. C et al.International journal of nuclear medicine & biology. 1985, Vol 12, Num 3, pp 175-184, issn 0047-0740Article

Biological behavior of erythrocytes labeled in vivo and in vitro with technetium-99 mATKINS, H. L; SRIVASTAVA, S. C; MEINKEN, G. E et al.Journal of nuclear medicine technology. 1985, Vol 13, Num 3, pp 136-139, issn 0091-4916Article

Radioactive gold cluster immunocongugates: potential agents for cancer therapyHAINFELD, J. F; FOLEY, C. J; SRIVASTAVA, S. C et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1990, Vol 17, Num 3, pp 287-294, issn 0883-2897, 7 p.Article

Comparative dual-tracer studies of carbon-14 tryptophan and iodine-131 HIPDM in animal models of pancreatic diseasesKUBOTA, K; SOM, P; BRILL, A. B et al.Journal of nuclear medicine. 1989, Vol 30, Num 11, pp 1848-1855, issn 0097-9058, 8 p.Article

A new cholescintigraphic agent: ruthenium-97-DISIDAZANZI, I; SRIVASTAVA, S. C; MEINKEN, G. E et al.Nuclear medicine and biology. 1989, Vol 16, Num 4, pp 397-403, issn 0969-8051, 7 p.Article

Thrombus radioimmunoscintigraphy: an approach using monoclonal antiplatelet antibodyOSTER, Z. H; SRIVASTAVA, S. C; SOM, P et al.Proceedings of the National Academy of Sciences of the United States of America. 1985, Vol 82, Num 10, pp 3465-3468, issn 0027-8424Article